Search

Your search keyword '"Casanova, Michela"' showing total 1,163 results

Search Constraints

Start Over You searched for: Author "Casanova, Michela" Remove constraint Author: "Casanova, Michela"
1,163 results on '"Casanova, Michela"'

Search Results

1. Plasma-derived extracellular vesicles miR-335–5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma

2. AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial

3. Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART

4. A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

6. Outcomes in lung-only metastatic rhabdomyosarcoma: An analysis of data from the European paediatric Soft tissue sarcoma Study Group MTS 2008 study

7. Secondary osteosarcoma: a challenge indeed

9. How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment

10. Nasopharyngeal Carcinoma

11. Liver Tumors

14. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

15. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

17. Foreign patients and multicultural challenges in pediatric oncology: The experience of the Istituto Nazionale dei Tumori in Milan.

20. Caring for children with cancer evacuated from Ukraine: The patients’ perception

21. Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis

22. Caring for children with cancer evacuated from Ukraine: the patients’ perception

24. The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma

25. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study

26. Correlation between oncological family history and clinical outcome in a large monocentric cohort of pediatric patients with rhabdomyosarcoma

27. Treatment at relapse for synovial sarcoma of children and adolescents: A multi-institutional European retrospective analysis

32. Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

33. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

34. Local treatment in initially unresected non‐rhabdomyosarcoma soft‐tissue sarcomas of children and adolescents: A retrospective single‐center experience

36. PROLONGED COVID-19 INFECTION IN A CHILD WITH LYMPHOBLASTIC NON HODGKIN LYMPHOMA: WHICH IS THE BEST MANAGEMENT?

37. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients

39. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

41. Supplementary Table S4 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

42. Data from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

43. Supplementary Figure S3 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

44. Supplementary Data S2 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

46. Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives

47. Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

49. Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

50. Regorafenib Plus Vincristine and Irinotecan in Pediatric Patients With Recurrent/Refractory Solid Tumors: An Innovative Therapies for Children With Cancer Study

Catalog

Books, media, physical & digital resources